ID: Eysb8t3MJ5
Title: GlucoSynth: Generating Differentially-Private Synthetic Glucose Traces
Conference: NeurIPS
Year: 2023
Number of Reviews: 16
Original Ratings: 6, 5, 5, 5, 5, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1
Original Confidences: 3, 3, 4, 3, 3, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1

Aggregated Review:
### Key Points
This paper presents GlucoSynth, a differential privacy (DP) generation model specifically designed for glucose data. The authors propose a motif causality block to learn dependencies between motifs, enhancing the model's ability to capture relationships beyond mere temporal dependencies. The architecture combines a GAN with an autoencoder, utilizing DP-SGD for training and PATE for the causality block, aiming to achieve robust DP guarantees.

### Strengths and Weaknesses
Strengths:
- The problem is well-motivated, with a clear summary of challenges in prior works.
- The motif causality block introduces a novel approach compared to existing methods.
- The application is practical, particularly in healthcare, and the evaluation metrics demonstrate improvements over previous literature.

Weaknesses:
- The writing becomes confusing in later sections, and the method's complexity raises concerns about efficiency and clarity.
- The contributions of the motif causality block and DP mechanisms lack clear experimental validation.
- The evaluation of performance metrics and the relationship between motifs require further clarification.

### Suggestions for Improvement
We recommend that the authors improve the clarity of the writing, particularly in Sections 3 and beyond, to enhance reader comprehension. Additionally, a well-designed ablation study should be included to elucidate how each module contributes to the overall model. We suggest providing more rigorous proofs of the privacy guarantees and detailed explanations of the motif causality block, including the rationale behind using specific hyperparameters like $\tau$. Finally, we encourage the authors to visualize the temporal dependencies learned by the model and to clarify the ethical considerations surrounding the use of sensitive healthcare data.